Skip to content
ORAMED PHARMACEUTICALS INC. (ORMP) Insider Trading
Home / Companies / ORMP ORM
ORAMED PHARMACEUTICALS INC. (ORMP) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest ORMP Insider Trades
About ORAMED PHARMACEUTICALS INC. (ORMP) Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
Headquarters NEW YORK, NY
Employees 13
Listed 2004
Exchange XNAS https://www.oramed.com SEC filings for ORMP on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 2 210,360 $942K Option exercise 2 100,000
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
ORMP Insider Transactions (Form 4) 53 31 Form 4 filings on record, the earliest from Nov 8, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Jul 1, 2026 JH Joshua Hexter - Officer Open-market sale Common Stock 137,000
Recent ORMP Form 8-K Filings 3
Recent ORMP Form 144 Notices of Proposed Sale 2 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Jul 1, 2026 - - - - View on EDGAR Jul 1, 2026 - - -
ORMP Insider Trading - FAQ
What is the latest insider trade for ORMP? ORAMED PHARMACEUTICALS INC. (ORMP) had 2 insider filings in the last 90 days, with the most recent on 2026-07-02. The full record for ORMP runs to 31 Form 4 filings, the earliest from 2024-11-08. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying ORMP stock? No insider purchases of ORMP were filed in the last 90 days.
How many insiders are selling ORMP stock? 2 insider sales of ORMP were filed in the last 90 days, totaling $942K.
Where can I see ORMP SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks ORMP Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow ORMP insider buys? Create a free InsiderAlpha account and press Watch on this page to add ORMP to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track ORMP insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free $185K
NK Nadav Kidron - Officer Tax withholding / forfeiture $148K
Mar 30, 2026
MK Miriam Kidron - Officer Tax withholding / forfeiture $1.44M
Mar 30, 2026
NK Nadav Kidron - Officer Grant or award 167,005 sh
Mar 17, 2026
Market cap $209.23M
P/E ratio 1.20
Dividend yield -
Average volume 300.7K
52 week high $5.47
52 week low $2.09
Today's high $5.15
Today's low $5.01
Open $5.14
Volume 154.1K
Previous close $5.10
Shares outstanding 41.60M Market cap
$209.23M
13 employees
ORMP Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 2 sales totaling $942K.
Most-Active ORMP Insiders - Last 90 Days 9 Jul 2, 2026 JH Joshua Hexter - Officer Option exercise Common Stock 50,000 $3.69 $185K
Jul 2, 2026 JH Joshua Hexter - Officer Option exercise Stock option (right to buy) 50,000 $0.00 -
Jul 1, 2026 AG Avraham Gabay - Officer Open-market sale Common Stock 73,360 $4.51 $331K
Mar 30, 2026 NK Nadav Kidron - Officer Tax withholding / forfeiture Common Stock 44,818 $3.31 $148K
Mar 30, 2026 MK Miriam Kidron - Officer Tax withholding / forfeiture Common Stock 435,084 $3.31 $1.44M
Mar 17, 2026 MK Miriam Kidron - Officer Grant or award Common Stock 119,558 $0.00 -
Mar 17, 2026 NK Nadav Kidron - Officer Grant or award Common Stock 167,005 $0.00 -
Mar 17, 2026 JH Joshua Hexter - Officer Grant or award Common Stock 95,889 $0.00 -
Mar 17, 2026 AG Avraham Gabay - Officer Grant or award Common Stock 95,889 $0.00 -
Mar 12, 2026 NK Nadav Kidron - Officer Gift Common Stock 100,000 $0.00 -
Jan 22, 2026 JH Joshua Hexter - Officer Option exercise Common Stock 19,000 $0.00 -
Jan 22, 2026 JH Joshua Hexter - Officer Option exercise Performance Stock Units 19,000 $0.00 -
Jan 22, 2026 MK Miriam Kidron - Officer Option exercise Common Stock 19,000 $0.00 -
Jan 22, 2026 MK Miriam Kidron - Officer Option exercise Performance Stock Units 19,000 $0.00 -
Jan 22, 2026 AG Avraham Gabay - Officer Option exercise Common Stock 19,000 $0.00 -
Jan 22, 2026 AG Avraham Gabay - Officer Option exercise Performance Stock Units 19,000 $0.00 -
Jan 22, 2026 NK Nadav Kidron - Officer Option exercise Common Stock 109,000 $0.00 -
Jan 22, 2026 NK Nadav Kidron - Officer Option exercise Performance Stock Units 109,000 $0.00 -
Jan 14, 2026 MK Miriam Kidron - Officer Gift Common Stock 86,166 $0.00 -
Dec 31, 2025 YR Yehuda Reznick - Director Grant or award Common Stock 30,000 - -
Dec 31, 2025 YR Yehuda Reznick - Director Grant or award Common Stock 6,250 - -
Dec 31, 2025 NK Nadav Kidron - Officer Grant or award Common Stock 232,640 $0.00 -
Dec 31, 2025 NK Nadav Kidron - Officer Grant or award Common Stock 327,000 $0.00 -
Dec 31, 2025 NK Nadav Kidron - Officer Grant or award Performance Stock Units 109,000 $0.00 -
Dec 31, 2025 MK Miriam Kidron - Officer Grant or award Common Stock 121,331 $0.00 -
Dec 31, 2025 MK Miriam Kidron - Officer Grant or award Common Stock 115,000 $0.00 -
Dec 31, 2025 MK Miriam Kidron - Officer Grant or award Performance Stock Units 19,000 $0.00 -
Dec 31, 2025 JH Joshua Hexter - Officer Grant or award Common Stock 97,328 $0.00 -
Dec 31, 2025 JH Joshua Hexter - Officer Grant or award Common Stock 115,000 $0.00 -
Dec 31, 2025 JH Joshua Hexter - Officer Grant or award Performance Stock Units 19,000 $0.00 -
Dec 31, 2025 AM Arie Mayer - Director Grant or award Common Stock 30,000 - -
Dec 31, 2025 AM Arie Mayer - Director Grant or award Common Stock 4,900 - -
Dec 31, 2025 DA Daniel Aghion - Director Grant or award Common Stock 30,000 - -
Dec 31, 2025 DA Daniel Aghion - Director Grant or award Common Stock 6,250 - -
Dec 31, 2025 AG Avraham Gabay - Officer Grant or award Common Stock 81,216 $0.00 -
Dec 31, 2025 AG Avraham Gabay - Officer Grant or award Common Stock 115,000 $0.00 -
Dec 31, 2025 AG Avraham Gabay - Officer Grant or award Performance Stock Units 19,000 $0.00 -
Jun 5, 2025 AM Arie Mayer - Director Grant or award Common Stock 30,000 - -
Jun 5, 2025 AM Arie Mayer - Director Grant or award Common Stock 6,975 - -
Jun 5, 2025 YR Yehuda Reznick - Director Grant or award Common Stock 30,000 - -
Jun 5, 2025 YR Yehuda Reznick - Director Grant or award Common Stock 8,370 - -
Jun 5, 2025 LS Leonard Sank - Director Grant or award Common Stock 30,000 - -
Jun 5, 2025 LS Leonard Sank - Director Grant or award Common Stock 6,510 - -
Jun 5, 2025 DA Daniel Aghion - Director Grant or award Common Stock 30,000 - -
Jun 5, 2025 DA Daniel Aghion - Director Grant or award Common Stock 8,371 - -
Nov 7, 2024 AG Avraham Gabay - Officer Grant or award Common Stock 30,000 - -
Nov 7, 2024 NK Nadav Kidron - Officer Grant or award Common Stock 45,000 - -
Nov 7, 2024 MK Miriam Kidron - Officer Grant or award Common Stock 30,000 - -
PAL $IONS
IONIS PHARMACEUTICALS INC
